Reigetsu Yoshikawa

989 total citations
36 papers, 711 citations indexed

About

Reigetsu Yoshikawa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Reigetsu Yoshikawa has authored 36 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Reigetsu Yoshikawa's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Reigetsu Yoshikawa is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Reigetsu Yoshikawa collaborates with scholars based in Japan, United States and South Korea. Reigetsu Yoshikawa's co-authors include Hidenori Yanagi, Tomoko Hashimoto-Tamaoki, Masafumi Noda, Yoshinori Fujiwara, M. Kusunoki, Tomohiko Yamamura, Takehira Yamamura, Jun-ichi Furuyama, Tohru Tsujimura and Joji Utsunomiya and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Reigetsu Yoshikawa

36 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reigetsu Yoshikawa Japan 12 292 243 236 160 155 36 711
Katsuyuki Kunieda Japan 13 288 1.0× 198 0.8× 164 0.7× 81 0.5× 45 0.3× 83 697
Renzo Hirayama Japan 19 447 1.5× 274 1.1× 355 1.5× 185 1.2× 67 0.4× 39 944
Ji Hun Kim South Korea 15 251 0.9× 337 1.4× 104 0.4× 93 0.6× 55 0.4× 25 629
Marianna Silletta Italy 14 224 0.8× 157 0.6× 214 0.9× 88 0.6× 28 0.2× 42 613
Bruno Torchio Italy 15 278 1.0× 193 0.8× 204 0.9× 83 0.5× 37 0.2× 37 970
Hiroko Funai Japan 11 148 0.5× 297 1.2× 168 0.7× 84 0.5× 67 0.4× 15 531
Jin He China 16 167 0.6× 570 2.3× 98 0.4× 110 0.7× 57 0.4× 47 907
Zuzana Čierna Slovakia 18 420 1.4× 340 1.4× 194 0.8× 62 0.4× 45 0.3× 47 930
Philipp Manegold United States 14 446 1.5× 404 1.7× 124 0.5× 115 0.7× 21 0.1× 23 919

Countries citing papers authored by Reigetsu Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Reigetsu Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reigetsu Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reigetsu Yoshikawa more than expected).

Fields of papers citing papers by Reigetsu Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reigetsu Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reigetsu Yoshikawa. The network helps show where Reigetsu Yoshikawa may publish in the future.

Co-authorship network of co-authors of Reigetsu Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Reigetsu Yoshikawa. A scholar is included among the top collaborators of Reigetsu Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reigetsu Yoshikawa. Reigetsu Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kudo, Masatoshi, Richard S. Finn, Manabu Morimoto, et al.. (2021). Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2). Liver Cancer. 10(5). 451–460. 9 indexed citations
2.
Kudo, Masatoshi, Takuji Okusaka, Kenta Motomura, et al.. (2020). Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial. Journal of Gastroenterology. 55(6). 627–639. 20 indexed citations
3.
4.
5.
Masuda, Norikazu, Hiroji Iwata, Kenjiro Aogi, et al.. (2016). Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study. Japanese Journal of Clinical Oncology. 46(12). 1088–1094. 6 indexed citations
6.
Fujiwara, Yoshinori, Reigetsu Yoshikawa, Masanori Tsujie, et al.. (2015). CD44, a cancer stemness marker, to predict poor clinical outcome of esophageal cancer patients after neoadjuvant chemoradiotherapy.. Journal of Clinical Oncology. 33(15_suppl). e15068–e15068. 3 indexed citations
7.
Yoshikawa, Reigetsu, Tohru Tsujimura, Lihua Tao, Norihiko Kamikonya, & Yoshinori Fujiwara. (2012). The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy. BMC Cancer. 12(1). 461–461. 17 indexed citations
8.
Fujiwara, Yoshinori, Reigetsu Yoshikawa, Norihiko Kamikonya, et al.. (2012). Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients. Oncology Reports. 28(2). 446–452. 11 indexed citations
9.
Takahashi, Chiaki, Yoshie Yoshikawa, Reigetsu Yoshikawa, et al.. (2009). Germline PTCH1 mutations in Japanese basal cell nevus syndrome patients. Journal of Human Genetics. 54(7). 403–408. 13 indexed citations
10.
Yoshikawa, Reigetsu, Hidenori Yanagi, Yoshinori Fujiwara, et al.. (2008). Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug. World Journal of Surgical Oncology. 6(1). 17–17. 30 indexed citations
11.
Yoshikawa, Reigetsu, Yoshiro Nakano, Lihua Tao, et al.. (2008). Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. British Journal of Cancer. 98(10). 1670–1674. 62 indexed citations
12.
Yoshikawa, Reigetsu. (2007). Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence. World Journal of Gastroenterology. 13(16). 2283–2283. 11 indexed citations
13.
Yoshikawa, Reigetsu. (2006). ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World Journal of Gastroenterology. 12(36). 5884–5884. 44 indexed citations
14.
Yoshikawa, Reigetsu, Hidenori Yanagi, Masafumi Noda, Takehira Yamamura, & Tomoko Hashimoto-Tamaoki. (2005). Polysaccharide-K (PSK) inhibits distant metastasis in colorectal cancer dependent on ECA39. Cancer Research. 65. 171–171. 1 indexed citations
15.
Yoshikawa, Reigetsu, Hidenori Yanagi, Masafumi Noda, et al.. (2005). Venous thromboembolism in colorectal cancer patients with central venous catheters for 5-FU infusion-based pharmacokinetic modulating chemotherapy. Oncology Reports. 13(4). 627–32. 6 indexed citations
16.
Yanagi, Hidenori, et al.. (2005). Doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis (FAP). Journal of Clinical Oncology. 23(16_suppl). 3609–3609. 1 indexed citations
17.
Yoshikawa, Reigetsu, M. Kusunoki, Hidenori Yanagi, et al.. (2001). Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.. PubMed. 61(3). 1029–37. 169 indexed citations
18.
Kusunoki, Masato, Hidenori Yanagi, Masafumi Noda, Reigetsu Yoshikawa, & Takehira Yamamura. (2000). Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases. Cancer. 89(6). 1228–1235. 33 indexed citations
19.
Yoshikawa, Reigetsu, et al.. (1995). EFFECT OF ASPIRIN ON THE INDUCTION OF APOPTOSIS IN COLORECTAL ADENOCARCINOMA CELL-LINES. Oncology Reports. 2(3). 361–4. 3 indexed citations
20.
Yoshikawa, Reigetsu, Takuya Hatada, M. Kusunoki, Tomohiko Yamamura, & Joji Utsunomiya. (1993). ASSESSMENT OF CELL-PROLIFERATION KINETICS IN FAMILIAL ADENOMATOUS POLYPOSIS BY PCNA IMMUNOSTAINING. International Journal of Oncology. 3(2). 341–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyuki Kunieda Breakdown of academic impact, for papers by Renzo Hirayama Breakdown of academic impact, for papers by Ji Hun Kim Breakdown of academic impact, for papers by Marianna Silletta Breakdown of academic impact, for papers by Bruno Torchio Breakdown of academic impact, for papers by Hiroko Funai Breakdown of academic impact, for papers by Jin He Breakdown of academic impact, for papers by Zuzana Čierna Breakdown of academic impact, for papers by Philipp Manegold
Rankless by CCL
2026